Search for a clinical trial
Other search option(s)
CARDINAL: A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients with Alport Syndrome - ES (terminated)
- Type of clinical trial : Drug clinical trial
- Recruiting project : No
- Status : Terminated trial
- Funding body(ies) :
- Geographic coverage : Global
- Sponsor : Reata pharmaceuticals
- Phase : II - III
Download document
Principal investigator of clinical trial
- INFORMATION NOT PROVIDED
- Institution: Information not provided - ES
- ADDRESS: NOT PROVIDED - ES
- SPAIN
- More information
- Phone
:
Information not provided - ES - Fax : -
Investigator of clinical trial
- INFORMATION NOT PROVIDED
- Servicio de Nefrología
- Hospital Universitari Vall d'Hebron
- Paseo Vall d'Hebron, 119-129
- 08035 BARCELONA
- SPAIN
- More information
- Phone : 34 93 489 30 00
- Fax : -
- Website
- Contact secretary :
email
Investigator of clinical trial
- INFORMATION NOT PROVIDED
- Servicio de Nefrología
- Hospital Clínico Universitario Virgen de la Arrixaca
- Carretera Cartagena-Madrid s/n
- 30120 EL PALMAR, MURCIA
- SPAIN
- More information
- Phone : 34 968 36 95 00
- Fax : 34 968 36 97 76
- Website
Investigator of clinical trial
- Dr Roser TORRA BALCELLS
- Servicio de Nefrología
- Fundació Puigvert
- Calle Cartagena, 340-350
- 08025 BARCELONA
- SPAIN
- More information
- Phone : 349 34 16 97 00 Ext. 4474
- Fax : -
- Website
Sponsor of clinical trial
- REATA PHARMACEUTICALS
- Reata Pharmaceuticals
- 2801 Gateway Drive, Suite 150
- TX 75063 IRVING
- UNITED STATES
- More information
- Phone : 001 (972) 865-2219
- Fax : -
- Website
- Contact secretary :
email
Last update: December 2020
Additional information
Further information on this research
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.